These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 18434235)

  • 1. Airway epithelial cell inflammatory signalling in cystic fibrosis.
    Jacquot J; Tabary O; Le Rouzic P; Clement A
    Int J Biochem Cell Biol; 2008; 40(9):1703-15. PubMed ID: 18434235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-inflammatory effect of miglustat in bronchial epithelial cells.
    Dechecchi MC; Nicolis E; Norez C; Bezzerri V; Borgatti M; Mancini I; Rizzotti P; Ribeiro CM; Gambari R; Becq F; Cabrini G
    J Cyst Fibros; 2008 Nov; 7(6):555-65. PubMed ID: 18815075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Early bronchial inflammation in cystic fibrosis].
    Puchelle E
    J Soc Biol; 2002; 196(1):29-35. PubMed ID: 12134630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of airway epithelium and blood neutrophils in the inflammatory response in cystic fibrosis.
    Terheggen-Lagro SW; Rijkers GT; van der Ent CK
    J Cyst Fibros; 2005 Aug; 4 Suppl 2():15-23. PubMed ID: 15967736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced IL-1beta-induced IL-8 production in cystic fibrosis lung epithelial cells is dependent of both mitogen-activated protein kinases and NF-kappaB signaling.
    Muselet-Charlier C; Roque T; Boncoeur E; Chadelat K; Clement A; Jacquot J; Tabary O
    Biochem Biophys Res Commun; 2007 Jun; 357(2):402-7. PubMed ID: 17420005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azithromycin fails to reduce inflammation in cystic fibrosis airway epithelial cells.
    Saint-Criq V; Ruffin M; Rebeyrol C; Guillot L; Jacquot J; Clement A; Tabary O
    Eur J Pharmacol; 2012 Jan; 674(1):1-6. PubMed ID: 22056837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Airway inflammation in cystic fibrosis: molecular mechanisms and clinical implications.
    Cohen-Cymberknoh M; Kerem E; Ferkol T; Elizur A
    Thorax; 2013 Dec; 68(12):1157-62. PubMed ID: 23704228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenosine receptors, cystic fibrosis, and airway hydration.
    Com G; Clancy JP
    Handb Exp Pharmacol; 2009; (193):363-81. PubMed ID: 19639288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What's new in CF airway inflammation: an update.
    Ratjen F
    Paediatr Respir Rev; 2006; 7 Suppl 1():S70-2. PubMed ID: 16798601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Physiopathology of cystic fibrosis lung disease].
    Chinet T
    Rev Mal Respir; 1999 Jun; 16(3):339-45. PubMed ID: 10472642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the amiloride-sensitive epithelial Na+ channel in the pathogenesis and as a therapeutic target for cystic fibrosis lung disease.
    Mall MA
    Exp Physiol; 2009 Feb; 94(2):171-4. PubMed ID: 19060118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammation and CFTR: might neutrophils be the key in cystic fibrosis?
    Witko-Sarsat V; Sermet-Gaudelus I; Lenoir G; Descamps-Latscha B
    Mediators Inflamm; 1999; 8(1):7-11. PubMed ID: 10704083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal spatial diffusion of Ca2+ in F508del-CFTR airway epithelial cells.
    Antigny F; Norez C; Cantereau A; Becq F; Vandebrouck C
    Respir Res; 2008 Oct; 9(1):70. PubMed ID: 18973672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationships between cystic fibrosis transmembrane conductance regulator, extracellular nucleotides and cystic fibrosis.
    Marcet B; Boeynaems JM
    Pharmacol Ther; 2006 Dec; 112(3):719-32. PubMed ID: 16828872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophil recruitment and airway epithelial cell involvement in chronic cystic fibrosis lung disease.
    Conese M; Copreni E; Di Gioia S; De Rinaldis P; Fumarulo R
    J Cyst Fibros; 2003 Sep; 2(3):129-35. PubMed ID: 15463861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokines and inflammatory mediators in cystic fibrosis.
    Courtney JM; Ennis M; Elborn JS
    J Cyst Fibros; 2004 Dec; 3(4):223-31. PubMed ID: 15698939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging therapies in cystic fibrosis.
    Anderson P
    Ther Adv Respir Dis; 2010 Jun; 4(3):177-85. PubMed ID: 20530065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammation in cystic fibrosis and its management.
    Döring G; Worlitzsch D
    Paediatr Respir Rev; 2000 Jun; 1(2):101-6. PubMed ID: 12531101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-inflammatory effects of azithromycin in cystic fibrosis airway epithelial cells.
    Cigana C; Nicolis E; Pasetto M; Assael BM; Melotti P
    Biochem Biophys Res Commun; 2006 Dec; 350(4):977-82. PubMed ID: 17045242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of IL-8 release from CFTR-deficient lung epithelial cells following pre-treatment with fenretinide.
    Vilela RM; Lands LC; Meehan B; Kubow S
    Int Immunopharmacol; 2006 Nov; 6(11):1651-64. PubMed ID: 16979119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.